Trial Profile
A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Streptococcal B vaccine conjugate (Primary)
- Indications Streptococcal infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK; Novartis Vaccines
- 31 Aug 2020 Results published in the Vaccine.
- 30 Mar 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 09 Nov 2015 Planned End Date changed from 1 Jun 2016 to 1 Apr 2016 as reported by ClinicalTrial.gov record.